蘇州固鍀(002079.SZ):擬使用自有資金購買理財產品的最高額度累計餘額不超7億元
格隆匯 3 月 22日丨蘇州固鍀(002079.SZ)公佈,公司於2021年3月19日召開了第七屆董事會第三次會議,審議通過了《關於蘇州固鍀電子股份有限公司使用自有資金購買理財產品的議案》,同意公司及其全資、控股子公司使用自有資金購買理財產品的最高額度累計餘額不超過人民幣7億元,並授權董事長在該額度範圍內行使決策權,該額度可循環使用,授權期限自2020年度股東大會審議通過之日起至2021年度股東大會召開之日止。
此次使用自有資金購買理財產品事項不構成關聯交易,已經公司第七屆董事會第三次會議審議通過,須提交公司2020年度股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.